Unit 4 Exam Flashcards
Non-contraceptive benefits of combination oral contraceptives
Decreased risk of ovarian, endometrial and colon cancer.
Decrease benign breast disease and ovarian cysts.
Decrease risk of endometriosis, fibroids, ovulation pain, PMS, PMDD, cramps, migraines and anemia.
Improves acne and hirsutism.
When to start oral contraceptives?
Day 1 start: first day of menses.
Sunday start: Sunday after menses (no weekend menstruation).
How long to use back up birth control after starting oral contraceptives?
7 days
Serious Side Effects of Oral Contraceptives
VTE
MI/Stroke (especially if over 35 and smoking)
Liver disorders
Minor Side Effects of Oral Contraceptives
Breast tenderness
N/V
HA
Bloating
Acne
Mood changes
Spotting
Side Effects of Progestin-Only Contraceptives
Irregular bleeding
Acne
Breast tenderness
Mood changes
HA/Migraines
N/V
Ovarian cysts
Weight gain
Fluid retention
Acne
ACHES Acronym
severe Abdominal pain (gallbladder).
Chest pain (PE or MI)
Headache (stroke, HTN, migraine)
Eye problems (stroke or HTN)
Severe leg pain (DVT)
Depo-Provera Dosing Schedule
Initiated within the first 5 days after menses.
Given every 13 weeks (if missed, perform pregnancy test).
Depo-Provera Side Effects (6)
Weight gain
HA
Dizziness
Nervousness
Amenorrhea
Irregular bleeding
Depo-Provera Long Term Effects
Can cause significant loss of bone mineral density (reversible after stopping).
Increase calcium and vitamin D intake and increase exercise.
Depo-Provera Population
Issue with daily compliance.
Safe in hx of CV disease, stroke, thromboembolism, PVD and hemoglobinopathies (sickle cell).
Slow reversal: 70% conceive within first year, 90% within first two years. Not a good option if someone wants to conceive after stopping birth control.
IUD Education
Highly effective (<1%) and easily reversible.
Hormonal (progestin-only) and non-hormonal options.
Only maintenance is checking strings after each period to ensure placement.
No associated decline in fertility.
Placed in office.
IUD Population
Dysmenorrhea
Menorrhagia
Anemia
Side Effects of IUDs
PID
Ectopic pregnancy
Uterine perforation
Expulsion
Ovarian cysts
Irregular bleeding
Amenorrhea
Pelvic pain
Contraindications for IUDs
Suspected pregnancy
Uterine abnormalities
PID
Unexplained vaginal bleeding
What contraceptive method has decreased efficacy in patients with high BMI?
Xulane Transdermal Patch (Noregestromin and ethyl estradiol)
Increased failure rates and increase VTE risk if over 198lbs or BMI >30.
Best Practices for Emergency Contraception
Stops ovulation from occurring.
Should be utilized within 120 hours (5 days) of unprotected sex.
After use of any regimen, pregnancy test should be performed if no menstruation occurs within 21 days.
Types of Emergency Contraceptives
Copper IUD
Levonorgestrel (LNg or Plan B or Julie)
Ulipreistal Acetate (UPA) “Ella”
Combinded estrogen progestin (Yuzpe regimen)
Copper IUD
Most effective (>99%) and can remain in place for continued contraception.
Up to 10 years.
Levonorgestrel (LNg) “Plan B or Julie”
94% effective
Given as single dose (1.5mg) or split dose (0.75 mg) 12 hours apart.
Most effective within first 3 days and less effective in those more than 165 lbs.
Ulipristal Acetate (UPA) “Ella”
98% effective.
Progesterone receptor antagonist - inhibits follicle rupture even near ovulation.
Single dose (30mg)
Most effective within first 3 days and less effective in those more than 195lbs.
Combined Estrogen Progestin (Yuzpe regimen)
Less effective than LNg and UPA
Given in two doses (100 mcg ethinyl estradiol plus 0.5 mg LNg followed by repeat dose 12 hours later)
Side effects: N/V
Treatment Order for Vulvovaginal Candidiasis (VVC)
1st line - OTC antifungals 1-7 days; or single dose oral fluconazole (150mg)
2nd line - Assess w/ cultures; treat with 7-14 days of topical antifungal; OR oral fluconazole 150 mg every 72 hours x 3 doses.
3rd line - Treat with 10-14 days topical azole; OR oral fluconazole with maintenance therapy for 6 months (150 mg PO weekly); monitor liver function.
Treatment Order for Trichomoniasis
1st line - Metronidazole or Tinidazole (2g single dose); OR metronidazole 500 mg BID x 7 days; treat sex partners and avoid sex until therapy complete AND symptoms free.
2nd line - Try alternative first line treatment; if recurrent failure, consult specialist.
Treatment Order for Bacterial Vaginosis
1st line - PO metronidazole (500 mg BID x 7 days); OR topical clindamycin cream (2% intravaginally x 7 days); OR metronidazole gel (0.75% intravaginally x 7 days).
2nd line - Treat recurrence with same or difference first line regimen; metronidazole gel (0.75% twice per week x 6 months).
Education Regarding Treatment of Bacterial Vaginosis
Metronidazole/Tinidazole - AVOID ALCOHOL: N/V if ingested during treatment or within 72 hours.
Clindamycin - May weaken latex condoms and diaphragms.
Avoid tight fitting clothes, allow vaginal ventilation, avoid douching or other hygiene products (esp. scented) that may alter pH.
Proper instillation of vaginal creams and suppositories - best to perform at bedtime, wear a pad or panty liner on underwear.
Hormone Therapy for Patient WITH Uterus
Progestin + synthetic estrogen (oral or transdermal)
*Estrogen alone can lead to endometrial hyperplasia and risk of endometrial cancer.
Hormone Therapy for Patient WITHOUT Uterus
Estrogen alone
Contraindications for Hormone Therapy in Menopause (6)
Estrogen-dependent neoplasia
Thrombophlebitis/thromboembolic disorder
Pregnancy
Undiagnosed vaginal bleeding
Uncontrolled HTN
Acute liver disease
Monitoring Considerations for Patients Taking Hormone Therapy (7)
Follow up 4-8 weeks after initiation and then 3-6 months.
Decision to continue HT reviewed yearly.
Note any vaginal bleeding, ensure mammograms/PAPs/DEXA UTD
Height/weight, lipids, BP, breast exam, full pelvic exam.
Should be dc’d 1-3 years after menopause.
Discontinue gradually (4-6 week intervals) to reduce rebound symptoms.
Use beyond 3-5 years no recommended d/t increased risk of breast cancer.
Best Treatment of Vasomotor Symptoms in Menopause when HT is Contraindicated
SSRI (Zoloft, Lexapro)
SNRI (Effexor, Pristiq)
Gabapentin
Clonidine
Progestin only
Paroxetine (Paxil) FDA approved for moderate to severe VMS.
Best Route/Treatment for GU Syndromes of Menopause (GSM)
HT - Low dose vaginal estrogen OR transdermal estrogen or ospemifene (nonestrogen): lower risk of VTE compared to PO.
Non-HT - Vaginal lubricant and moisturizers and continued sexual intercourse.
Routes: Vaginal tablets, rings or cream.
Medications Used to Treat Pelvic Inflammatory Disease (6)
Cephalosporins (“Cef-“)
Doxycycline
Clindamycin
Gentamycin
Probenecid
Metronidazole
IV Treatment Used to Treat Pelvic Inflammatory Disease (PID)
Ceftriaxone + doxycycline + metronidazole
Cefotetan + doxycycline
Cefoxitin + doxycycline
Ampicillin-sulbactam + doxycycline
Clindamycin + gentamincin
IM or PO Treatment Used to Treat Pelvic Inflammatory Disease (PID)
Ceftriaxone + doxycycline + metronidazole
Cefoxitin + probenecid + doxycycline + metronidazole
3rd gen cephalosporin + doxycycline + metronidazole
Treatment of Gonorrhea for Patients with Cephalosporin Allergy
Gentamycin IM + Azithromycin PO
Suppressive Therapy for Genital Herpes
Acyclovir (more frequent dosing d/t decrease bioavailability; pregnancy).
Valacyclovir (Used in pregnancy)
Famciclovir
Treatment of Pregnant Patients with Chlamydia
Azithromycin 1g PO x 1 dose (Amox is alternative)
Considerations of treatment of chlamydia in pregnant patients
Doxy is contraindicated in 2nd-3rd trimester
Retest 3-4 weeks after treatment and again after 3 months to make sure it is not going to be passed to child during birth
Patient-Applied treatments for genital warts
Imiquimod (Aldara)
Podofilox (Condylox)
Sinecatechins (Green tea extract product)
Treatment of pregnant patients with syphilis and allergy to penicillin
PCN G = only effective treatment
Desensitize mom to PCN and then treat with PCN G.
Allows temporary tolerance.
Treatment of erectile dysfunction
1st line - Phosphodiesterase-5 inhibitors (PDE-5)
2nd - line refer to urologist.
Complementary - Yohimbine, ginkgo bilboa, ginseng, HCG, L-arginine
Examples of PDE-5 Inhibitors
Tadalafil (Cialis)
Vardenafil (Levitra)
Sildenafil (Viagra)
Avanafil (Stendra)
Contraindications of PDE-5 Inhibitors (12)
Concurrent use of NITRATES
Alpha-blockers
Unstable angina
Hypotension
Uncontrolled HTN
Recent stroke
Arrhythmia
MI within 6 months
Severe HF
Renal failure
Liver failure
Potent CYP450 inhibitor
Antimuscarinics MOA
Inhibit binding of Ach at muscarininc receptors M3 on detrusor smooth muscle cells, causing relaxation and increase bladder filling capacity.
Antimuscarinics Adverse Effects
Anticholinergic side effects (xerostomia, constipation, urinary retention).
*Can’t see, can’t spit, can’t pee, can’t shit.
Antimuscarinics Contraindications
Narrow angle glaucoma
Urinary retention
Use of other drugs metabolized by CYP-450